|Fostering the growth of a diverse clinical & translational workforce.||Program for Faculty Development & Diversity Inclusion|
This summer six medical school and ten college students from across the United States are in Boston to take part in an immersive, experiential, pipeline training in clinical and translational science through two summer internship programs offered through Harvard Catalyst's Program for Faculty Development and Diversity Inclusion (PFDDI).
The Visiting Research Internship Program (VRIP) is an eight-week mentored summer internship program for first- and second-year medical students and the Summer Clinical and Translational Research Program (SCTRP) offers college students (sophomores and above) the opportunity for ten weeks of mentored research. Both pipeline programs are designed to enrich students' interest in research and health-related careers, particularly clinical/translational research careers, to increase the exposure of underrepresented minority and disadvantaged students to clinical and translational research and prime the C/T career path with a diverse constituency.
Students in both VRIP & SCTRP attend a series of seminars conducted by HMS faculty, which parallel and underscore a concurrent six-week boot-camp version of the Fundamentals of Clinical and Translational Research (FaCToR) online course. Summer interns also take part in other events, such as networking dinners and career development seminars in Longwood and the Harvard Catalyst hospital partner departments of their lab hosts.
PFDDI has matched students accepted into both internship programs with laboratories at HMS and the affiliated hospitals and partner institutions in order to give the students an intensive experience that exposes them to the breadth of work that falls under the umbrella of clinical and translational science. Each year the VRIP and SCTRP summer programs collaborate with other Harvard Catalyst programs to maximize the learning and research resources available to program participants. This year, a few of the new labs and centers include: Brigham and Women's Hospital, Department of Psychiatry; Brigham and Women's Hospital, Tissue Engineering and Wound Healing Laboratory; Boston Children's Hospital, Department of Anesthesiology, Perioperative, and Pain Medicine; Massachusetts General Hospital, Laboratory for Computational Neuroimaging; Harvard T.H. Chan School of Public Health; and the Veterans Affairs Boston Healthcare System (VABHS), Cardiac Surgery Research.
If you are interested in learning more about this program and the 2016 intern cohort's summer outcomes, please — Save the Date — of Thursday, July 28, for the VRIP Closing Ceremony from 8:00am to 11:00am in the Waterhouse Room of Gordon Hall at Harvard Medical School. Meanwhile the SCTRP Closing Ceremony is scheduled for Thursday, August 11, from 9:00am to 1:00pm in the Waterhouse Room. For questions or to RSVP for either event, please email Danyellé Thorpe.
Finally, if you are a PI or mentor interested in participating in future summer sessions of VRIP & SCTRP, please email program manager Carol Martin.
2016 VRIP Student Interns June 6 - July 29, 2016
Shaleeka Cornelius, Meharry Medical College, School of Medicine
Mentor: Suzanne Walker, PhD, Heidi Morris and Michael Quinn, Harvard Medical School, Department of Microbiology and Immunobiology**
Chigozie Emetarom, Central Michigan University College of Medicine
Mentor: Brittany Charlton, MSc, ScD, Boston Children's Hospital, Sexual Orientation and Gender Identity and Expression (SOGIE) Working Group
Adrian Godoy Vazquez, Howard University College of Medicine
Mentor: Dusica Bajic, MD, PhD, Boston Children's Hospital, Department of Anesthesiology, Perioperative and Pain Medicine
Ngoda Manongi, Stony Brook University School of Medicine
Mentors: Camilia Martin, MD, MS/Steven Freedman, MD, PhD, Beth Israel Deaconess Medical Center, Martin-Freedman Lab**
Anjelica Saulsberry, University of Tennessee Health Science Center College of Medicine
Mentor: Laura Holsen, PhD, Brigham and Women's Hospital, Department of Psychiatry
Meghna Srinath, University of Missouri School of Medicine
Mentor: Eleftheria Maratos-Flier, MD, and Sarah Flier, MD, Beth Israel Deaconess Medical Center, Flier & Maratos-Flier Lab**
2016 SCTRP Student Interns June 6 - August 12, 2016
Grace Ahn, Cornell University
Mentor: Alexander Lin, PhD, Brigham and Women's Hospital, Center for Clinical Spectroscopy**
Alexandra Capellini, Johns Hopkins University
Mentor: Raymond Huang, MD, PhD, Brigham and Women's Hospital, Department of Neuroradiology**
Garlyn Colas, Johns Hopkins University
Mentor: Einat Liebenthal, DSc, Brigham and Women's Hospital, Functional Neuroimaging Laboratory
Breland Crudup, Tougaloo College
Mentor: Iman Aganj, PhD, and Bruce Fischl, PhD Massachusetts General Hospital, Laboratory for Computational Neuroimaging
Alexander Jeremiah, Tufts University
Mentor: Bernardo Lemos, PhD, Harvard T.H. Chan School of Public Health, Lemos Lab
Keturah Kiper, University of Arkansas
Mentor: Michael Super, PhD and Anna Waterhouse, PhD, Wyss Institute for Biologically Inspired Engineering**
Eseosa Odigie, Cornell University
Mentor: Ronilda Lacson, MD, PhD, Brigham and Women's Hospital, Center for Evidence Based Imaging**
Mariana Serrano, Eastern Connecticut State University
Mentor: Jacquelyn Quin, MD, Annette Phillips and Jennifer Gabany, Veterans Affairs Boston Healthcare System (VABHS), Cardiac Surgery Research
Trevon Waters, Norfolk State University
Mentor: Dennis P. Orgill, MD, PhD, and Giorgio Giatsidis, MD, Brigham and Women's Hospital, Tissue Engineering and Wound Healing Laboratory
Bethel Yeshiwas, University of Virginia
Mentor: Synho Do, PhD, Massachusetts General Hospital, Laboratory of Medical Imaging and Computation and Rapid Collaboration Hub (RCH)
* indicates returning mentor
** indicates multi-year mentor
A two-year, non-degree Faculty Fellowship Program for Harvard junior faculty. The fellowship is designed to address faculty need for additional support to conduct clinical and/or translational research and to provide release time to junior faculty from clinical and teaching demands at a key point in their career development. The fellowship provides $100,000 over a two-year period to support scholarly efforts. Faculty fellows are required to have dedicated research time toward the development of their academic career, to meet regularly with their mentors, and to present at the Minority Health Policy Annual Meeting.
We are very pleased to announce the 2016 Harvard Catalyst/Program for Faculty Development and Diversity Inclusion Faculty Fellow is Dr. Natasha M. Archer.
Natasha M. Archer, MD, MPH, Instructor, Harvard Medical School; Department of Pediatrics, Boston Children's Hospital
Mentor: David Nathan, MD, Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School; President Emeritus, Dana-Farber Cancer Institute
Division Chief: David A. Williams, MD, Leland Fikes Professor of Pediatrics, Harvard Medical School; Chief, Division of Hematology/Oncology, Department of Pediatrics, Boston Children's Hospital
Project Title: "The Effect of Fetal Hemoglobin on Plasmodium Falciparum Invasion and Growth"
P. falciparum, the deadliest of malaria parasites, massively but sequentially degrades hemoglobin subunits beginning with plasmepsin I and II cleavage at α 33-34. Fetal hemoglobin (HbF) is composed of 2 α and 2 γ chains. Due to enhanced α/γ relative to α/β dimer stability, the α chains of HbF may be relatively more resistant to parasitic plasmepsin I and II cleavage as compared to HbA conferring protection from intraerythrocyte growth of P. falciparum to neonates and those with hemoglobinopathies such as hemoglobin (Hb) S, C and E and β-thalassemia, all characterized by high HbF. While others have demonstrated increased invasion but decreased P. falciparum growth in high HbF-containing human and human γ-transgenic murine red cells, the fraction of HbF in erythrocytes required for malaria inhibition, and the mechanism by which HbF exerts this effect, are unknown. Characterizing HbF's role in P. falciparum infection will help lead to further understanding of how HbF and medications that increase it, such as hydroxyurea, will affect patients with hemoglobinopathies who live in malaria endemic regions.
Natasha M. Archer, MD, MPH, is a pediatric hematologist/oncologist at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an instructor in pediatrics at Harvard Medical School, and associate physician in the Division of Global Health Equity at Brigham and Women's Hospital. She is also the senior health and policy advisor for Hematology at Partners In Health (PIH), a Boston-based non-profit health care organization. Dr. Archer's research focuses on the delivery of effective hematology care in resource-limited settings. Dr. Archer has helped the PIH team in Mirebalais, Haiti, set up a program for newborn screening and disease management for sickle cell disease. Her ongoing clinical research focuses on ways to effectively diagnosis and manage anemia in Haiti. In addition, Dr. Archer's translational research explores the relationship between hemoglobin and malaria infectivity. Dr. Archer completed her fellowship in pediatric hematology/oncology at Dana-Farber/Boston Children's in 2014 and her medicine and pediatrics residency in the Harvard Combined Internal Medicine/Pediatrics Residency training program. She completed the Doris and Howard Hiatt Global Health Equity Residency in 2011. Dr. Archer earned her BS from Yale University in 1999, her MD from Yale University School of Medicine in 2006, and her MPH from Harvard School of Public Health in 2011.
Visiting Research Internship Program (VRIP) Judge, Mentor, and Simulation Faculty, Alden Landry, MD, MPH, featured in Beth Israel Deaconess Medical Center (BIDMC) newsletter.